GDC-0980 - CAS# 1032754-93-0 Size:Solid 2 mg SB-269970 has been used to

SB-269970 has been used to target the 5-HT7 receptor in the study of schizophrenia-like cognitive deficits

ClH/c1-3-18-8-11-21(12-9-18)31-16-19-6-4-5-7-22(19)26(30)29-20-10-13-25-23(15-20)24(27)14-17(2)28-25

CAS Number: 274901-16-5

Etofibrate enhances or decreases plasma glycerol levels depending on both the dose and the time after treatment

2Sr/c13-2-6-5(1-7(15)16)10(12(21)22)23-11(6)14(3-8(17)18)4-9(19)20

GDC-0980 - CAS# 1032754-93-0 Size:Solid 2 mg SB-269970 has been used toApitolisib, also known as GDC 0980 and RG7422; or GNE390, is a dual PI3 kinase mTOR inhibitor, is also a n orally available agent targeting phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K mTOR signaling pathway, with potential antineoplastic activity. PI3K mTOR kinase inhibitor GDC 0980 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition of cancer